Tanvex BioPharma
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10394 Pacific Center Ct, San Diego, Cali...Phone Number
(858) 210-4100Website
www.tanvex.comRevenue
$34.6 MillionStock Symbol
6541Industry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Tanvex BioPharma
Tanvex BioPharma, Inc. (TWSE: 6541) is a biopharmaceutical company focused on the biosimilar market. The Company is vertically integrated with end-to-end in-house development, manufacturing and commercialization capabilities. Tanvex BioPharma, Inc. is registered in Cayman Islands and has operations and facilities in Irvine, CA, San Diego, CA, and Taipei, Taiwan. Tanvex is publicly traded on the Taiwan Stock Exchange.Explore more
Tanvex BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tanvex BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tanvex BioPharma recently announced quarterly report
Check out if Tanvex BioPharma is spiking on competitors!
Click to see if Tanvex BioPharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Tanvex BioPharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Tanvex BioPharma
Tanvex BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Tanvex BioPharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Tanvex BioPharma launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Tanvex BioPharma as Masked Content
Find more new buyers
Compare Similar Companies to Tanvex BioPharma
Compare insights from companies similar to Tanvex BioPharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$19.3M
51-200
Private
-
2008
TS
Trushant ShahNeo Wealth & Asset Management Vice President, Corporate Strategy
Company Profile Activity
Activity Insights
Tanvex BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tanvex BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tanvex BioPharma.
Tanvex BioPharma financials insights
Gather financial insights about Tanvex BioPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
Tanvex BioPharma Tech Stack
A closer look at the technologies used by Tanvex BioPharma
Most Recent Scoops
Open Position
Open Position
Hiring Plans
Tanvex BioPharma has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Tanvex BioPharma News & Media
HER2 Positive Breast Cancer Pipeline 2024 | Byondis, Tanvex Biopharma, Prestige BioPharma, EirGenix, AMbrx,
HER2 Positive Breast Cancer Pipeline DELHI, DELHI, INDIA, July 3, 2024 /EINPresswire.com/ -- DelveInsight’s, “HER2 Positive Breast Cancer Pipeline Insight 2024” report provides comprehensive insights about 60+ companies and 65+ pipeline drugs in HER2 …Tanvex BioPharma Secures Asia's First FDA Approval for Filgrastim Biosimilar, Seizing a ...
Tanvex BioPharma secured Asia's first FDA approval for a filgrastim biosimilar, capturing a $403 million market.Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars
New biologics outsourcing solution provider leverages proven track record of Tanvex BioPharma USA Inc. to help early-stage companies bring mammalian and microbial derived biologics from concept to commercialization.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tanvex BioPharma
Sign Up For FreeTo access detailed company insights
Tanvex BioPharma, Inc. (TWSE: 6541) is a biopharmaceutical company focused on the biosimilar market. The Company is vertically integrated with end-to-end in-house development, manufacturing and commercialization capabilities. Tanvex BioPharma, Inc. is registered in Cayman Islands and has operations and facilities in Irvine, CA, San Diego, CA, and T... Read More
